Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 4
Submit an article Journal homepage
250
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

The DEP regimen is superior to the HLH-1994 regimen as first-line therapy for lymphoma-associated haemophagocytic lymphohistiocytosis

Guangqiang MengDepartment of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Yini WangDepartment of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
,
Jingshi WangDepartment of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaView further author information
&
Zhao WangDepartment of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 854-860 | Received 10 Mar 2020, Accepted 31 Oct 2020, Published online: 21 Nov 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Halil Yildiz, Sarah Bailly, Eric Van Den Neste & Jean Cyr Yombi. (2021) Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies. Therapeutics and Clinical Risk Management 17, pages 293-304.
Read now

Articles from other publishers (9)

Qi Kong, Min Li, Jingshi Wang, Lin Wu, Dunhua Zhou, Minghua Yang, Xiaojun Xu, Zhen Tan, Xiaoyan Wu & Zhao Wang. (2023) Prognostic scoring system for pediatric Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study. Pediatric Blood & Cancer.
Crossref
Yubo Pi, Jingshi Wang, Hui Zhou, Xiujin Ye, Xiuhua Sun, Ligen Liu, Xueyi Pan & Zhao Wang. (2022) Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study. Journal of Cancer Research and Clinical Oncology 149:7, pages 3033-3041.
Crossref
Fei Xiao, Shihui Hou, Kaizhen Kui, Xiaoyue Wang, Lihua Bai & Huanzi Dai. (2023) Case report of extranodal natural killer/T-cell lymphoma that induced secondary hemophagocytic syndrome-related histiocytic glomerulopathy. Journal of International Medical Research 51:5, pages 030006052311589.
Crossref
Qiaolei Zhang, Lulu Wang, De Zhou, Lixia Zhu, Li Li, Wanzhuo Xie, Yamin Tan & Xiujin Ye. (2022) Clinical features and prognostic analysis of lymphoma‑associated hemophagocytic syndrome: A report of 139 cases. Oncology Letters 25:1.
Crossref
Pascal Migaud, Markus Müller, Keikawus Arastéh, Marcus Hentrich & Hartmut Stocker. (2022) Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders. Annals of Hematology 101:10, pages 2281-2287.
Crossref
Qing-Yuan Xu, Hai-Yan Yang, Mei-Wei Li, Zhen-Dong He, Hao-Yuan Hong & Zhi-Gang Peng. (2022) Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review. Medicine 101:38, pages e30731.
Crossref
Ailin Zhao, Jinrong Yang, Meng Li, Linfeng Li, Xinai Gan, Jie Wang, He Li, Kai Shen, Yunfan Yang & Ting Niu. (2022) Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients. Frontiers in Immunology 13.
Crossref
Qiaolei Zhang, Youyan Lin, Yejiang Bao, Yuan Jin, Xiujin Ye & Yamin Tan. (2022) Analysis of Prognostic Risk Factors and Establishment of Prognostic Scoring System for Secondary Adult Hemophagocytic Syndrome. Current Oncology 29:2, pages 1136-1149.
Crossref
Cheng-Hsien Lin, Yu-Hsuan Shih, Tsung-Chih Chen, Cheng-Wei Chou, Chiann-Yi Hsu & Chieh-Lin Jerry Teng. (2021) A Decade of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: Does the Outcome Improve?. Journal of Clinical Medicine 10:21, pages 5114.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.